Delivering precision medicine in oncology today and in future—the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delivering precision medicine in oncology today and in future—the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 25, Issue 9, Pages 1673-1678
Publisher
Oxford University Press (OUP)
Online
2014-06-21
DOI
10.1093/annonc/mdu217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer evolution: the final frontier of precision medicine?
- (2014) C. Swanton ANNALS OF ONCOLOGY
- The evolution of the unstable cancer genome
- (2014) Rebecca A Burrell et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cost Effectiveness ofEML4-ALKFusion Testing and First-Line Crizotinib Treatment for Patients With AdvancedALK-Positive Non–Small-Cell Lung Cancer
- (2014) Sandjar Djalalov et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Personalised cancer management: closer, but not here yet
- (2013) M. Piccart ANNALS OF ONCOLOGY
- European Consensus Conference for external quality assessment in molecular pathology
- (2013) J. H. van Krieken et al. ANNALS OF ONCOLOGY
- The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
- (2013) R. A. Popescu et al. ANNALS OF ONCOLOGY
- Biomarkeranalytik aus Sicht des Pathologen
- (2013) R. Buettner et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Lessons from the Cancer Genome
- (2013) Levi A. Garraway et al. CELL
- Journeys into the genome of cancer cells
- (2013) Michael R. Stratton EMBO Molecular Medicine
- Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab
- (2013) C. Leopold et al. HEALTH POLICY
- Ethical, Legal, and Counseling Challenges Surrounding the Return of Genetic Results in Oncology
- (2013) Martijn P. Lolkema et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges
- (2013) Rodrigo Dienstmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomics-Driven Oncology: Framework for an Emerging Paradigm
- (2013) Levi A. Garraway JOURNAL OF CLINICAL ONCOLOGY
- Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment
- (2013) Reinhard Buettner et al. JOURNAL OF CLINICAL ONCOLOGY
- Existing and Emerging Technologies for Tumor Genomic Profiling
- (2013) Laura E. MacConaill JOURNAL OF CLINICAL ONCOLOGY
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Preparing for Responsible Sharing of Clinical Trial Data
- (2013) Michelle M. Mello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
- (2013) Yaping Yang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed
- (2013) H. L. McLeod SCIENCE
- Reflections on Market Access for Personalized Medicine: Recommendations for Europe
- (2013) Katherine Payne et al. VALUE IN HEALTH
- A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect
- (2013) Michael P Boyle et al. Lancet Respiratory Medicine
- Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) S. Peters et al. ANNALS OF ONCOLOGY
- Knowledge engineering for health: A new discipline required to bridge the “ICT gap” between research and healthcare
- (2012) Tim Beck et al. HUMAN MUTATION
- Unlocking the value of personalised healthcare in Europe—breast cancer stratification
- (2012) Walter Van Dyck et al. Health Policy and Technology
- International network of cancer genome projects
- (2010) Thomas J. Hudson (Chairperson) et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started